A new study has evaluated the effectiveness of different treatment options for basal cell carcinoma. Learn more.

In a randomized trial, recurrence was higher after superficial curettage (SC) plus imiquimod cream than surgical excision (SE) in patients with nodular basal cell carcinoma (nBCC). At 5 years ...

An example of a small, superficial BCC lesion that might be treated with imiquimod. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert!

Imiquimod is an ... TLR7/8 and used to treat basal cell carcinomas. The researchers employed various preclinical mouse tumor models of melanoma and breast cancer. What both tumors have in common ...

Imiquimod, another topical, is FDA-approved for basal cell carcinomas as well as solar keratoses. It stimulates the immune system to treat the area affected with skin cancer.” A laser treatment ...

(A) A young woman being treated with imiquimod for a superficial basal-cell carcinoma on the cheek. (B) Six months after treatment the erythema within the area has cleared with no residual tumor ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically.

Imiquimod is an ... TLR7/8 and used to treat basal cell carcinomas. The researchers employed various preclinical mouse tumor models of melanoma and breast cancer. What both tumors have in common ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically.

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically.